{"id":86718,"date":"2023-12-07T00:07:30","date_gmt":"2023-12-07T05:07:30","guid":{"rendered":"https:\/\/www.hedgeco.net\/news\/?p=86718"},"modified":"2023-12-06T22:56:35","modified_gmt":"2023-12-07T03:56:35","slug":"abbvie-to-acquire-neuroscience-drugmaker-cerevel-therapeutics-for-8-7-billion","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/12\/2023\/abbvie-to-acquire-neuroscience-drugmaker-cerevel-therapeutics-for-8-7-billion.html","title":{"rendered":"AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion"},"content":{"rendered":"\n<p>(CNBC)  <a href=\"https:\/\/www.cnbc.com\/quotes\/ABBV\/\">AbbVie<\/a> on Wednesday said it will acquire neuroscience drugmaker <a href=\"https:\/\/www.cnbc.com\/quotes\/CERE\/\">Cerevel Therapeutics<\/a> for roughly $8.7 billion.\u00a0 Under the <a rel=\"noreferrer noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/abbvie-to-acquire-cerevel-therapeutics-in-transformative-transaction-to-strengthen-neuroscience-pipeline-302008134.html\" target=\"_blank\">terms of the deal<\/a>, AbbVie will pay $45 per share for Cerevel. AbbVie said it expects to complete the acquisition in the middle of 2024.\u00a0 Shares of Cerevel jumped <strong>16%<\/strong> after the close Wednesday to nearly $43 per share, just below the purchase price. <\/p>\n\n\n\n<p><a href=\"https:\/\/www.cnbc.com\/2023\/12\/06\/abbvie-to-acquire-cerevel-therapeutics-for-8point7-billion-.html\">To read this article:<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(CNBC) AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion.\u00a0 Under the terms of the deal, AbbVie will pay $45 per share for Cerevel. AbbVie said it expects to complete the acquisition in the [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-86718","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/86718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=86718"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/86718\/revisions"}],"predecessor-version":[{"id":86719,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/86718\/revisions\/86719"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=86718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=86718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=86718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}